| Generic name | Mitomycin |
| Pronunciation | my-toh-MY-sin |
| Brand name(s), other common name(s) | Mutamycin® |
| Drug type | Antineoplastic |
| How the drug is given | Intravenously (IV) |
Indications and Usage
Mitomycin is FDA approved to treat people who have advanced adenocarcinoma of the stomach or pancreas in combination with other approved chemotherapeutic agents and as palliative treatment when other treatments have failed. This medication is sometimes prescribed for other uses such as bladder and lung cancer. Mitomycin sometimes causes a temporary loss of hair. After treatment has ended, normal hair growth should return.
Side effects needing medical attention
If mitomycin accidentally seeps out of the vein, it may damage the skin and cause scarring. Your healthcare provider should be notified right away if you notice redness, pain or swelling at the IV site; blood in urine; difficulty breathing or shortness of breath; fever, chills or sore throat; unusual bleeding or bruising; cough; decreased urination; sores in mouth or on lips; swelling of feet or lower legs; bloody vomit; unusual tiredness or fatigue; blurred vision; loss of appetite; nausea and vomiting; drowsiness; headache.
Side effects needing medical attention after stopping this medication
Blood in urine; fever, chills or sore throat; unusual bleeding or bruising; decreased urination; shortness of breath; swelling of feet or lower legs; unusual tiredness or fatigue.
For information on how to manage the costs of drug therapy, please see Financial Support, or to speak with an Information Specialist, call (800) 955-4572.